MS
Morgan Stanley
MS has lower modeled downside risk, despite its lower overall score.
RM
Regional Management Corp.
RM has a slight edge over MS overall, supported by stronger valuation.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
RM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
RM's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like RM.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
RM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.6x | $27.45 | -21% |
| Forward | 5.6x | $34.74 | — |
| Current | 7x | $34.74 | — |
| Fair | 8.4x | $41.46 | +19% |
| Expensive | 12x | $59.24 | +71% |
Historical ranges are pointers, not guarantees.
RM has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
RM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for RM, with profitability improving. However, they disagree widely on these estimates.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over RM on earnings, with stronger typical year-over-year growth.
RM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.23 | +26% |
| Q3 2026 | $4.94 | +20% |
| Q2 2026 | $4.75 | +38% |
| Q1 2026 | $4.93 | +50% |
| Q4 2025 | $4.45 | +7.5% |
| Q3 2025 | $4.11 | +71% |
| Q2 2025 | $3.45 | +35% |
| Q1 2025 | $3.28 | +41% |
| Q4 2024 | $4.14 | +149% |
RM's earnings per share have fallen from their peak: $4.94 over the past year, against $8.69 in early 2022.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over RM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over RM on profitability, with a higher operating margin.
RM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $178.8M | +8% |
| Q2 2026 | $168M | +6.7% |
| Q1 2026 | $167.3M | +9.4% |
| Q4 2025 | $169.7M | +9.6% |
| Q3 2025 | $165.5M | +13% |
| Q2 2025 | $157.4M | +10% |
| Q1 2025 | $153M | +6% |
| Q4 2024 | $154.8M | +9.3% |
RM's revenue has grown year over year for 23 quarters in a row: $179M last quarter, up 8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -0.4 points |
| Q2 2026 | 6.3% | -2.3 points |
| Q1 2026 | 8.9% | +2.9 points |
| Q4 2025 | 9.5% | +1.3 points |
| Q3 2025 | 11% | +4.5 points |
| Q2 2025 | 8.6% | +0.7 points |
| Q1 2025 | 6% | -7.8 points |
| Q4 2024 | 8.2% | +15 points |
RM's operating margin was 11% last quarter, about level with the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
RM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $81.7M | -4.6% |
| Q2 2026 | $79.3M | +2.1% |
| Q1 2026 | $79.9M | +28% |
| Q4 2025 | $78.6M | +26% |
| Q3 2025 | $85.7M | +16% |
| Q2 2025 | $77.6M | +10% |
| Q1 2025 | $62.4M | +8.6% |
| Q4 2024 | $62.3M | -5.3% |
RM has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
RM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -242K shares |
| 1 year | -7.6% | -771K shares |
| 3 years | -3% | -288K shares |
| 5 years | -11% | -1.2M shares |
| Available history | -20% | -2.4M shares |
RM has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10M |
| Q2 2026 | $5.1M |
| Q1 2026 | $7.5M |
| Q4 2025 | $7.5M |
| Q3 2025 | $5M |
| Q2 2025 | $5M |
| Q1 2025 | $6.5M |
| Q4 2022 | — |
RM spent $30M buying back its own shares over the past year.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS has the edge over RM on leverage, with a lower net debt burden relative to earnings.
RM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 21.6x | High |
| Q2 2026 | 21.1x | High |
| Q1 2026 | 19.9x | High |
| Q4 2025 | 22.1x | High |
| Q3 2025 | 22.5x | High |
| Q2 2025 | 24.9x | High |
| Q1 2025 | 25.5x | High |
| Q4 2024 | 21.5x | High |
RM's net debt is more than 20 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like RM.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
RM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 50.3 | Neutral |
RM's weekly RSI is 50 (neutral) and its Stochastic is 50 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
RM PE vs Financial Services Sector
| Metric | RM | Sector median | Relative |
|---|---|---|---|
| PE | 7x | 13x | 46% below |
| PE % | 28 | 63 | 35 pts below |
RM has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over RM on trend strength, trading above more of its moving averages.
RM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.8 | 2.7% above |
| 20 week MA | $35.1 | 1.1% below |
| 50 week MA | $35.8 | 2.9% below |
| 100 week MA | $35.0 | 0.8% below |
| 200 week MA | $31.6 | 10% above |
RM's trend is mixed: it's above two of its five weekly moving averages, and 10% above its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over RM on returns for 2026, with the stronger performance.
RM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $28.6 | -3.4% |
| 2021 | $28.6 | $57.2 | +100% |
| 2022 | $57.2 | $27.7 | -52% |
| 2023 | $27.7 | $25.1 | -9.4% |
| 2024 | $25.1 | $33.7 | +34% |
| 2025 | $33.7 | $40.1 | +19% |
| 2026 YTD | $40.1 | $34.7 | -13% |
RM's yearly returns have swung widely, from +100% in 2021 to −52% in 2022. It's down 13% so far in 2026.